T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy

BACKGROUND: Multiple sclerosis (MS) is a neurological disorder marked by accumulating immune-mediated damage to the central nervous system. The dysregulated immune system in MS combined with immune effects of disease-modifying therapies (DMTs) used in MS treatment could alter responses to infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Reder, Anthony T, Stuve, Olaf, Tankou, Stephanie K, Leist, Thomas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Topical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708532/
https://www.ncbi.nlm.nih.gov/pubmed/36440826
http://dx.doi.org/10.1177/13524585221134216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708532/
https://www.ncbi.nlm.nih.gov/pubmed/36440826
http://dx.doi.org/10.1177/13524585221134216

Ejemplares similares